6IZN image
Deposition Date 2018-12-20
Release Date 2019-03-27
Last Version Date 2023-11-22
Entry Detail
PDB ID:
6IZN
Keywords:
TRANSCRIPTION
Title:
Crystal structure of the PPARgamma-LBD complexed with compound 3g
Biological Source:
Source Organism:
Homo sapiens (Taxon ID: 9606)
Host Organism:
Escherichia coli
Method Details:
Experimental Method:
X-RAY DIFFRACTION
Resolution:
1.75 Å
R-Value Free:
0.26
R-Value Work:
0.23
R-Value Observed:
0.23
Space Group:
P 1 21 1
6IZN validation report
Macromolecular Entities
Protein Blast
Polymer Type:polypeptide(L)
Molecule:Peroxisome proliferator-activated receptor gamma
Gene (Uniprot):PPARG
Chain IDs:A
Chain Length:283
Number of Molecules:1
Biological Source:Homo sapiens
UniProt ID:P37231 Pfam ID:PF00104
Protein Blast
Polymer Type:polypeptide(L)
Molecule:Peptide from Peroxisome proliferator-activated receptor gamma coactivator 1-alpha
Gene (Uniprot):PPARGC1A
Chain IDs:B (auth: C)
Chain Length:19
Number of Molecules:1
Biological Source:Homo sapiens
UniProt ID:Q9UBK2
Ligand Molecules
B1O
Primary Citation
Structure-Activity Relationship Studies of 3- or 4-Pyridine Derivatives of DS-6930.
Acs Med.Chem.Lett. 10 358 362 (2019)
PMID: 30891140 DOI: 10.1021/acsmedchemlett.8b00645

Abstact

Derivatization efforts were continued to discover backups for a potent selective PPARγ modulator, DS-6930. In this Letter, the replacement of 2-pyridine ring in DS-6930 with 3- or 4-pyridyl group is reported. As the introduction of substituents on the pyridine ring did not provide potent partial agonists, modifications of benzimidazole ring were explored to discover potent intermediate agonists. 4'-Alkoxy substituted benzimidazoles failed to show potent efficacy in vivo, whereas 7'-fluoro benzimidazole 3g (DS19161384) was found to result in robust plasma glucose reductions with excellent DMPK profiles.

Legend

Protein

Chemical

Disease

Primary Citation of related structures
6IZN